JP2018514589A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018514589A5 JP2018514589A5 JP2018507796A JP2018507796A JP2018514589A5 JP 2018514589 A5 JP2018514589 A5 JP 2018514589A5 JP 2018507796 A JP2018507796 A JP 2018507796A JP 2018507796 A JP2018507796 A JP 2018507796A JP 2018514589 A5 JP2018514589 A5 JP 2018514589A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- pharmaceutical composition
- cannabinoid
- thc
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021057991A JP2021107401A (ja) | 2015-04-29 | 2021-03-30 | カンナビノイドとｎ−アシルエタノールアミンの組み合わせ |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562154144P | 2015-04-29 | 2015-04-29 | |
| US62/154,144 | 2015-04-29 | ||
| PCT/IL2016/050414 WO2016174661A1 (en) | 2015-04-29 | 2016-04-19 | Combinations of cannabinoids and n-acylethanolamines |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021057991A Division JP2021107401A (ja) | 2015-04-29 | 2021-03-30 | カンナビノイドとｎ−アシルエタノールアミンの組み合わせ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018514589A JP2018514589A (ja) | 2018-06-07 |
| JP2018514589A5 true JP2018514589A5 (enExample) | 2019-05-30 |
| JP6938465B2 JP6938465B2 (ja) | 2021-09-22 |
Family
ID=57199061
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018507796A Active JP6938465B2 (ja) | 2015-04-29 | 2016-04-19 | カンナビノイドとｎ−アシルエタノールアミンの組み合わせ |
| JP2021057991A Pending JP2021107401A (ja) | 2015-04-29 | 2021-03-30 | カンナビノイドとｎ−アシルエタノールアミンの組み合わせ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021057991A Pending JP2021107401A (ja) | 2015-04-29 | 2021-03-30 | カンナビノイドとｎ−アシルエタノールアミンの組み合わせ |
Country Status (12)
| Country | Link |
|---|---|
| US (7) | US11234956B2 (enExample) |
| EP (2) | EP3288553B1 (enExample) |
| JP (2) | JP6938465B2 (enExample) |
| CN (2) | CN107530317A (enExample) |
| AU (4) | AU2016254685B2 (enExample) |
| CA (1) | CA2984088C (enExample) |
| DK (1) | DK3288553T3 (enExample) |
| ES (1) | ES2935605T3 (enExample) |
| IL (2) | IL291864A (enExample) |
| MA (1) | MA41997A (enExample) |
| PL (1) | PL3288553T3 (enExample) |
| WO (1) | WO2016174661A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6938465B2 (ja) * | 2015-04-29 | 2021-09-22 | エスシーアイ スパーク リミティド | カンナビノイドとｎ−アシルエタノールアミンの組み合わせ |
| WO2019136351A1 (en) * | 2018-01-05 | 2019-07-11 | Altus Labs, Llc | Personal care compositions |
| US20220000833A1 (en) * | 2018-01-29 | 2022-01-06 | Therapix Biosciences Ltd. | Compositions and methods for treating obstructive sleep apnea |
| MX2020010424A (es) * | 2018-04-03 | 2021-01-15 | Pure Green Pharmaceuticals Inc | Comprimido o composicion que contiene n-acil etanolamina y cannabinoides. |
| WO2020160452A1 (en) * | 2019-02-01 | 2020-08-06 | Tess Ventures, Inc. | Combining serms, sarms, and cannabinoids for improving safety and efficacy of endocrine therapies |
| WO2020214569A1 (en) * | 2019-04-15 | 2020-10-22 | Metagenics, Inc. | Novel hemp and pea formulation and its use |
| MX2021012892A (es) * | 2019-04-23 | 2021-11-17 | Scisparc Ltd | Composiciones y metodos para potenciar derivados de 4-aminofenoles. |
| EP3965789A4 (en) * | 2019-05-07 | 2023-01-25 | Ojai Energetics PBC | PROCEDURE FOR OPTIMIZING CANNABINOID DOSAGE DETERMINATION |
| EP3972573A4 (en) | 2019-05-23 | 2023-07-12 | India Globalization Capital, Inc. | COMPOSITIONS AND METHODS OF USING CANNABINOIDS TO TREAT STAMMING/STOMMING AND SYMPTOMS OF TOURETTE SYNDROME |
| EP4017486A4 (en) * | 2019-08-19 | 2023-09-20 | Buzzelet Development And Technologies Ltd | COMPOSITIONS FOR TREATING A CONDITION CHARACTERIZED BY ANANDAMID DEFICIENCY AND USES THEREOF |
| EP3838346A1 (en) * | 2019-12-20 | 2021-06-23 | Chemo Research SL | Soft gelatin capsules comprising palmitoylethanolamide and alpha-lipoic acid |
| WO2021141959A1 (en) | 2020-01-10 | 2021-07-15 | Pacira Pharmaceuticals, Inc. | Treatment of pain by administration of sustained-release liposomal anesthetic compositions |
| WO2021141963A1 (en) | 2020-01-10 | 2021-07-15 | Pacira Pharmaceuticals, Inc. | Treatment of pain by subarachnoid administration of sustained-release liposomal anesthetic compositions |
| US11273122B2 (en) | 2020-02-11 | 2022-03-15 | Therese Mainella | Combination of cannabis, derivatives thereof and additives in oral care compositions |
| EP4274573A4 (en) | 2021-01-11 | 2024-12-11 | Pacira Pharmaceuticals, Inc. | TREATMENT OF HIP PAIN WITH LIPOSOMAL SUSTAINED-RELEASE ANESTHESIA COMPOSITIONS |
| WO2023278768A1 (en) * | 2021-06-30 | 2023-01-05 | Demetrix, Inc. | Alleviation of itching sensations using cannabinoid compounds |
| WO2023039419A2 (en) | 2021-09-08 | 2023-03-16 | Plantible Foods Inc. | Systems and methods for measuring mat density of aquatic biomass |
| WO2023200906A1 (en) | 2022-04-12 | 2023-10-19 | Shackelford Pharma Inc. | Treatment of seizure disorders |
| US11918565B1 (en) | 2022-11-03 | 2024-03-05 | Pacira Pharmaceuticals, Inc. | Treatment of post-operative pain via sciatic nerve block with sustained-release liposomal anesthetic compositions |
| US12226610B2 (en) | 2022-11-03 | 2025-02-18 | Pacira Pharmaceuticals, Inc. | Treatment of pain associated with total knee arthroplasty with sustained-release liposomal anesthetic compositions |
| WO2024124354A1 (en) * | 2022-12-16 | 2024-06-20 | Aima Inc. | Compositions and methods for treating or preventing pain or other disorders |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2330681C (en) * | 1998-05-29 | 2008-08-26 | Andrea Giuffrida | Control of pain with endogenous cannabinoids |
| US6949582B1 (en) * | 1999-05-27 | 2005-09-27 | Wallace Walter H | Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment |
| GB2394894B (en) * | 2002-11-04 | 2005-08-31 | G W Pharma Ltd | New use for pharmaceutical composition |
| US20090054526A1 (en) | 2005-07-14 | 2009-02-26 | Hansen Harald S | Inhibitors of anorexic lipid hydrolysis for the treatment of eating disorders |
| GB2432312A (en) * | 2005-11-01 | 2007-05-23 | Gw Pharma Ltd | Pharmaceutical compositions for the treatment of pain |
| ES2548190T3 (es) * | 2009-09-07 | 2015-10-14 | Epitech Group S.P.A. | Composición que contiene palmitoiletanolamida ultramicronizada |
| AT509000B1 (de) * | 2009-10-23 | 2012-12-15 | Rausch Peter | Wasserlösliche zubereitungen von cannabinoiden und cannabispräparaten und deren anwendungen |
| GB2495118B (en) * | 2011-09-29 | 2016-05-18 | Otsuka Pharma Co Ltd | A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD) |
| EP2719375A1 (en) * | 2012-10-10 | 2014-04-16 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Cannabinoids for the treatment of cancers dependent on hedgehog mechanisms |
| JP6938465B2 (ja) * | 2015-04-29 | 2021-09-22 | エスシーアイ スパーク リミティド | カンナビノイドとｎ−アシルエタノールアミンの組み合わせ |
-
2016
- 2016-04-19 JP JP2018507796A patent/JP6938465B2/ja active Active
- 2016-04-19 EP EP16786064.2A patent/EP3288553B1/en active Active
- 2016-04-19 ES ES16786064T patent/ES2935605T3/es active Active
- 2016-04-19 IL IL291864A patent/IL291864A/en unknown
- 2016-04-19 PL PL16786064.2T patent/PL3288553T3/pl unknown
- 2016-04-19 CN CN201680024534.5A patent/CN107530317A/zh active Pending
- 2016-04-19 AU AU2016254685A patent/AU2016254685B2/en active Active
- 2016-04-19 CN CN202310678191.6A patent/CN116549437A/zh active Pending
- 2016-04-19 WO PCT/IL2016/050414 patent/WO2016174661A1/en not_active Ceased
- 2016-04-19 DK DK16786064.2T patent/DK3288553T3/da active
- 2016-04-19 EP EP22215663.0A patent/EP4193993A3/en active Pending
- 2016-04-19 MA MA041997A patent/MA41997A/fr unknown
- 2016-04-19 US US15/570,118 patent/US11234956B2/en active Active
- 2016-04-19 CA CA2984088A patent/CA2984088C/en active Active
-
2017
- 2017-10-24 IL IL255238A patent/IL255238B/en unknown
-
2019
- 2019-08-30 US US16/557,379 patent/US11207290B2/en active Active - Reinstated
- 2019-10-01 US US16/589,611 patent/US20200030281A1/en not_active Abandoned
- 2019-10-10 US US16/598,029 patent/US11197845B2/en active Active - Reinstated
-
2021
- 2021-03-30 JP JP2021057991A patent/JP2021107401A/ja active Pending
- 2021-07-19 AU AU2021206784A patent/AU2021206784B2/en active Active
- 2021-08-27 US US17/459,583 patent/US20210393577A1/en active Pending
- 2021-11-12 US US17/524,942 patent/US20220071948A1/en not_active Abandoned
- 2021-11-12 US US17/525,046 patent/US20220071949A1/en active Pending
-
2023
- 2023-10-17 AU AU2023251426A patent/AU2023251426B2/en active Active
-
2025
- 2025-12-31 AU AU2025287414A patent/AU2025287414A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2542868T3 (es) | Terapia de combinación para el tratamiento de diabetes asociada con la obesidad | |
| EP3288553B1 (en) | Combinations of cannabinoids and n-acylethanolamines | |
| ES2988617T3 (es) | Norketotifeno para el tratamiento de la hipercitocinemia y las infecciones virales | |
| EP3236960B1 (en) | Fluralaner for use in the treatment of demodicosis | |
| AU2016201325B2 (en) | Methods Of Providing Weight Loss Therapy In Patients With Major Depression | |
| CA2973698A1 (en) | Compositions and methods for inhibiting fungal infections | |
| CN117177743A (zh) | 包含依维莫司和安森司群的组合 | |
| KR20250079059A (ko) | 모발 성장 자극을 위한 알파-케토부티레이트, 알파-케토글루타레이트, 및 2-하이드록시부티레이트 | |
| AU2019299213A1 (en) | Cannabidiol combination compositions | |
| US20260102374A1 (en) | Methods of treating bacterial infections | |
| WO2021207325A1 (en) | Natural extract and their components for use in mitigating acute respiratory distress syndrome | |
| JP2014533692A (ja) | 虚血による神経細胞障害を低減するためのアポエクオリン | |
| EA022711B1 (ru) | Комбинация дибромида 1,12-додекаметилен-бис-[4-метил-5-(2-гидроксиэтил)тиазолия] и артесуната для лечения тяжелой формы малярии | |
| EP4236931B1 (en) | Compositions comprising tetrahydrocannabinol for treating acute respiratory failure and/or acute respiratory distress syndrome | |
| CN116549455A (zh) | PLK4抑制剂Centrinone在制备治疗包虫病药物中的应用 | |
| US20190224208A1 (en) | Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation | |
| US20060211672A1 (en) | Use of estrogen receptor-beta selective agonists for radiation-or chemotherapy-induced mucositis and radiation cystitis | |
| CN110693903B (zh) | 一种治疗急性单核细胞白血病的药物及三氧化二砷和双氢青蒿素的应用 | |
| KR20220111620A (ko) | 코비드-19 감염증의 예방 또는 치료용 약제학적 조성물 | |
| US20230263812A1 (en) | Compositions and Methods for Treating COVID-19 and/or Acute Respiratory Failure and/or Acute Respiratory Distress Syndrome Using Tetrahydrocannabinol and Compositions Including Same | |
| AU726664B2 (en) | Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone | |
| CN112641765B (zh) | 丙泊酚的抗疲劳制药用途 | |
| EP4098254A1 (en) | Cannabidiol for use in the treatment of pain resulting from an indoleamine 2,3-dioxygenase-1 (ido1) related disease | |
| US20060128738A1 (en) | Treatment of interstitial cystitis using cannabinoid analogs | |
| US20070093519A1 (en) | Anti-emetic uses of cannabinoid analogs |